The Gazette on MSN5d
Three years and waiting for Canada's made-in-Montreal COVID shot
Vaccine production is nearly three years behind schedule at a federally owned plant in Montreal and the future of a deal ...
Reuters on MSN1d
Canada approves Moderna’s RSV vaccine, first of its kind for older adults
Moderna said on Friday that Canada’s health regulator has approved its vaccine for respiratory syncytial virus (RSV) in adults 60 years and older, making it the country’s first authorized ...
Do COVID-19 boosters still make sense? What to know about the latest vaccine rollout
Canada’s panel of vaccine advisers has strongly recommended the new vaccines targeting the KP.2 strain, part of the Omicron lineage, for the previously vaccinated or unvaccinated at increased risk ...
Updated COVID-19 vaccine available in Ontario as of today. Who is eligible, and where to get yours
Health officials say eligible residents can receive the COVID-19 vaccine at the same time as or at any time before or after ...
Mpox vaccine doses divvied up for 9 African countries
The allocated vaccines are from European countries, the United States, Canada and Gavi, a public-private alliance that co-funds vaccine purchases for low-income countries. 2nd mpox vaccine dose ...
CTV News9d
Vaccine clinics planned as two additional cases of measles confirmed in New Brunswick
Two more cases of measles have been confirmed in New Brunswick, bringing the total number of cases to five. On Oct. 24, New ...
GlobalData on MSN3d
GSK’s RSV vaccine approved in Canada for adults aged 50 to 59
GSK has received approval for its vaccine, AREXVY, in Canada to prevent LRTD caused by RSV in adults aged 50 to 59 years.
Pfizer, GSK, Moderna struggle in a shrinking RSV vaccine market
Q3 results confirmed on Thursday that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (NYSE:PFE) and GSK (NYSE:GSK), is shrinking. Cambridge, Massachusetts-based Moderna ...